PetIQ, Inc. PETQ
Set alert
At close · Oct 24
52-week range unavailable
- Open
- 30.99
- Prev close
- 30.98
- Mkt cap
- 926.64M
- Vol
- 928.27K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 30.98
- High
- 31.00
- Forward P/E
- 15.81
- Beta
- 1.74
- Short ratio
- 1.58
- Inst. own
- 102.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2024
- 50-d avg
- 30.73
- 200-d avg
- 22.52
- 1y target
- 30.50
2Y chart
Events in this range
- Aug 8, 2023Earnings: —; estimate 0.26; surprise —%
- Sep 6, 2023Rating: Lake Street · — → Buy
- Oct 2, 2023Rating: Truist Securities · Buy → Buy
- Nov 7, 2023Earnings: —; estimate 0.03; surprise —%
- Dec 19, 2023Rating: Jefferies · — → Buy
- Feb 28, 2024Earnings: —; estimate -0.29; surprise —%
- Mar 19, 2024Rating: Jefferies · Buy → Buy
- May 8, 2024Earnings: —; estimate 0.42; surprise —%
- May 10, 2024Rating: Benchmark · Buy → Buy
- Aug 7, 2024Earnings: —; estimate 0.49; surprise —%
- Aug 8, 2024Downgrade: Truist Securities · Buy → Hold
Signals (94)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Aug 27, 2024 | 2 years ago |
| SMA: Bullish | Aug 7, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 7, 2024 | 2 years ago |
| RSI: Overbought | Aug 7, 2024 | 2 years ago |
| SMA: Bearish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Jul 31, 2024 | 2 years ago |
| SMA: Bearish | Jul 30, 2024 | 2 years ago |
| SMA: Bullish | Jul 25, 2024 | 2 years ago |
| SMA: Bearish | Jul 24, 2024 | 2 years ago |
| RSI: Overbought | Jul 1, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 17, 2024 | 2 years ago |
| RSI: Overbought | Jun 17, 2024 | 2 years ago |
| RSI: Overbought | May 30, 2024 | 2 years ago |
| RSI: Overbought | May 13, 2024 | 2 years ago |
| SMA: Bullish | May 9, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| MACD: Buy Signal | May 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 11, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 11, 2024 | 2 years ago |
| SMA: Bearish | Apr 9, 2024 | 2 years ago |
| SMA: Bullish | Mar 28, 2024 | 2 years ago |
| SMA: Bullish | Mar 28, 2024 | 2 years ago |
| SMA: Bearish | Mar 27, 2024 | 2 years ago |
| SMA: Bullish | Mar 26, 2024 | 2 years ago |
| MACD: Buy Signal | Mar 20, 2024 | 2 years ago |
| SMA: Bearish | Mar 1, 2024 | 2 years ago |
| MACD: Sell Signal | Mar 1, 2024 | 2 years ago |
| SMA: Bearish | Feb 28, 2024 | 2 years ago |
| SMA: Bullish | Feb 27, 2024 | 2 years ago |
| SMA: Bearish | Feb 21, 2024 | 2 years ago |
| SMA: Bullish | Feb 15, 2024 | 2 years ago |
| SMA: Bearish | Feb 13, 2024 | 2 years ago |
| SMA: Bullish | Feb 12, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 12, 2024 | 2 years ago |
| SMA: Bearish | Jan 9, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 5, 2024 | 2 years ago |
| SMA: Bullish | Dec 19, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 6, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 16, 2023 | 2 years ago |
| SMA: Bearish | Nov 13, 2023 | 2 years ago |
| SMA: Bullish | Nov 10, 2023 | 2 years ago |
| SMA: Bearish | Nov 8, 2023 | 2 years ago |
| SMA: Bullish | Nov 7, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 7, 2023 | 2 years ago |
| SMA: Bearish | Nov 6, 2023 | 2 years ago |
| SMA: Bullish | Nov 3, 2023 | 2 years ago |
| SMA: Bearish | Oct 19, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 16, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 29, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 28, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 22, 2023 | 3 years ago |
| SMA: Bullish | Sep 12, 2023 | 3 years ago |
| SMA: Bearish | Sep 11, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 28, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 7, 2023 | 3 years ago |
| RSI: Overbought | Aug 7, 2023 | 3 years ago |
| MACD: Sell Signal | Aug 2, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 1, 2023 | 3 years ago |
| RSI: Overbought | Jul 31, 2023 | 3 years ago |
| RSI: Overbought | Jul 25, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 21, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 18, 2023 | 3 years ago |
| RSI: Overbought | Jul 17, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 30, 2023 | 3 years ago |
| RSI: Overbought | Jun 29, 2023 | 3 years ago |
| RSI: Overbought | Jun 13, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 6, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 5, 2023 | 3 years ago |
| MACD: Buy Signal | Jun 2, 2023 | 3 years ago |
| MACD: Sell Signal | May 26, 2023 | 3 years ago |
| MACD: Buy Signal | May 10, 2023 | 3 years ago |
| RSI: Overbought | May 10, 2023 | 3 years ago |
| MACD: Sell Signal | May 9, 2023 | 3 years ago |
| MACD: Buy Signal | May 5, 2023 | 3 years ago |
| MACD: Sell Signal | May 4, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 20, 2023 | 3 years ago |
| SMA: Bullish | Apr 19, 2023 | 3 years ago |
| SMA: Bearish | Apr 18, 2023 | 3 years ago |
| SMA: Bullish | Apr 13, 2023 | 3 years ago |
| SMA: Bearish | Apr 11, 2023 | 3 years ago |
| SMA: Bullish | Apr 10, 2023 | 3 years ago |
| SMA: Bearish | Apr 5, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 30, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 3, 2023 | 3 years ago |
| SMA: Bullish | Mar 2, 2023 | 3 years ago |
| SMA: Bearish | Feb 17, 2023 | 3 years ago |
| SMA: Bullish | Feb 15, 2023 | 3 years ago |
| SMA: Bearish | Feb 10, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 8, 2023 | 3 years ago |
| RSI: Overbought | Feb 1, 2023 | 3 years ago |
| SMA: Bullish | Jan 9, 2023 | 3 years ago |
| MACD: Buy Signal | Jan 9, 2023 | 3 years ago |
| RSI: Oversold | Dec 28, 2022 | 3 years ago |
| RSI: Overbought | Nov 30, 2022 | 3 years ago |
Key statistics
- Market cap
- 926.64M
- Enterprise value
- 1.30B
- Trailing P/E
- 83.73
- Forward P/E
- 15.81
- PEG ratio
- 0.68
- Price / sales
- 0.82
- Price / book
- 3.56
- EPS (TTM)
- 0.37
- Beta
- 1.74
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.16%
- Revenue (TTM)
- 1.13B
- Revenue growth
- 4.60%
- Free cash flow
- 2.18M
- Total cash
- 84.13M
- Total debt
- 460.59M
- Return on equity
- 5.52%
- Shares outstanding
- 29.67M
- Short % of float
- 3.72%
- 50-day average
- 30.73
- 200-day average
- 22.52
Analyst view
Consensus: buy
- Target (low)
- 30.00
- Target (mean)
- 30.50
- Target (high)
- 31.00
- Strong buy2
- Buy2
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2024
Expected Nov 5, 2024. Consensus EPS estimate 0.49.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2024 | Sep 1, 2024 | 0.36 | — | — | — |
| Aug 7, 2024 | Jun 1, 2024 | 0.49 | — | — | — |
| May 8, 2024 | Mar 1, 2024 | 0.42 | — | — | — |
| Feb 28, 2024 | Dec 1, 2023 | -0.29 | — | — | — |
| Nov 7, 2023 | Sep 1, 2023 | 0.03 | — | — | — |
| Aug 8, 2023 | Jun 1, 2023 | 0.26 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 8, 2024 | Truist Securities | down | Buy | Hold |
| May 10, 2024 | Benchmark | reit | Buy | Buy |
| Mar 19, 2024 | Jefferies | main | Buy | Buy |
| Dec 19, 2023 | Jefferies | init | — | Buy |
| Oct 2, 2023 | Truist Securities | main | Buy | Buy |
| Sep 6, 2023 | Lake Street | init | — | Buy |
About PetIQ, Inc.
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which sells flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as third-party branded products for dogs and cats. It also provides OTC medications and supplies primarily within the flea and tick control, dog dewormers, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dog and cat treats, oral health solutions, stain and odor treatments, and pet nutritional supplements under the PetArmor®, Rocco & Roxie®, VetIQ®, Minties® and Sentry® brands. It provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PurLuv, Rocco & Roxie, Minties, Heart Shield Plus, and TruProfen brand names. In addition, the company operates veterinarian service platform through community clinics, pop-up locations, wellness centers, and permanent locations that offer cost effective and convenient veterinary wellness services, including diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene, and wellness checks; and provides veterinary care services. It operates through veterinarian, retail, and e-commerce channels. PetIQ, Inc. was founded in 2010 and is headquartered in Eagle, Idaho. As of October 25, 2024, PetIQ, Inc. was taken private.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- petiq.com
News
- Bansk Group Announces Sale of PetIQ's Veterinary Services Business to Tractor Supply Company
- PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group
- PetIQ, Inc. Announces Results of Special Meeting of Stockholders
- SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Upcoming Votes of PETQ and FBMS
- STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS
- STOCKHOLDER ALERT: The M&A Class Action Firm Investigates the Mergers and Imminent Votes of PETQ and FBMS
- PetIQ, Inc. (PETQ) Hits Fresh High: Is There Still Room to Run?
- Fast-paced Momentum Stock PetIQ (PETQ) Is Still Trading at a Bargain
- PetIQ (PETQ) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Should Value Investors Buy PetIQ (PETQ) Stock?
Your note
Sign in to keep a note on PETQ — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CARTER WILLIAM JOHN | General Counsel | Conversion of Exercise of derivative security | Aug 27, 2024 | 3,497 |
| CHRISTENSEN MCCORD | Chief Executive Officer | Conversion of Exercise of derivative security | Oct 24, 2024 | 0 |
| FIRST MARK L | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 18,547 |
| HALL ALLAN | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 12,807 |
| HUFF SCOTT | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 18,194 |
| LEFKO KIMBERLY | Director | Conversion of Exercise of derivative security | Jun 20, 2024 | 14,822 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.14% | 3,009,661 | 93.24M | Jun 29, 2024 |
| Vanguard Group Inc | 7.39% | 2,191,956 | 67.91M | Jun 29, 2024 |
| Eos Management, L.P. | 6.65% | 1,972,687 | 61.11M | Jun 29, 2024 |
| Dimensional Fund Advisors LP | 4.17% | 1,236,632 | 38.31M | Jun 29, 2024 |
| Aristotle Capital Boston, LLC | 4.15% | 1,232,590 | 38.19M | Jun 29, 2024 |
| Boston Partners | 3.51% | 1,039,987 | 32.22M | Jun 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.78% | 826,067 | 25.59M | Jun 29, 2024 |
| iShares Russell 2000 ETF | 2.37% | 703,083 | 21.78M | Sep 29, 2024 |
| Thornburg Small/Mid Cap Core Fund | 2.15% | 637,975 | 19.76M | Jun 29, 2024 |
| Arbitrage Fund | 1.54% | 458,008 | 14.19M | Aug 30, 2024 |
| Vanguard Extended Market Index Fund | 1.38% | 408,882 | 12.67M | Jun 29, 2024 |
| Oberweis Micro-Cap Portfolio | 1.15% | 340,700 | 10.55M | Jun 29, 2024 |